“Our north star for more than 20 years has been to address the underlying cause of cystic fibrosis, treat more people with this disease, and bring more people to normal levels of CFTR function ...

The drugmaker, with almost $10 billion in sales last year, has significantly impacted cystic fibrosis treatment, turning it from a disease with a median death age of around 30 years to a ...